Market Overview:
The global tizanidine market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of neurological disorders, increasing awareness about the benefits of tizanidine, and growing demand for generic drugs. Based on type, the global tizanidine market is segmented into 2mg tablet, 4mg tablet, 2mg capsules, 4mg capsules, and 6mg capsules. The 2 mg tablet segment is expected to account for the largest share of the global tizanidine market in 2018. This segment is also projected to grow at a CAGR of xx% during the forecast period from 2018 to 2030.
Product Definition:
Tizanidine is a drug used to treat muscle spasms. It is a centrally acting muscle relaxant that works by blocking the action of certain chemicals in the brain that cause muscles to tighten.
2mg Tablet:
2mg tablet is a form of drug containing 2 milligrams of tizanidine. It's an anti-epileptic drug used to prevent or reduce seizures in patients with epilepsy. Epilepsy is a chronic and incurable neurological disorder which causes repeated and unprovoked seizures. The incidence rate of epilepsy is rising globally, thus making it one of the most common chronic diseases affecting the population today.
4mg Tablet:
4mg tablet is used for the treatment of chronic constipation. It works by slowing down and relaxing the movement of food through the digestive system. This drug belongs to a group of drugs called stool-retention agents, which prevent diarrhea as well as constipation. Tizanidine is used in patients who are suffering from chronic idiopathic constipation (CIC) or Chronic Inflammatory Bowel Disease (CIBD).
Application Insights:
Adults segment held the largest share of more than 60.0% in 2017. The growing usage of tizanidine for treating chronic pain and anxiety is driving the segment growth. Moreover, increasing number of clinical trials supporting its use for the treatment of pain in adults is expected to propel demand over the forecast period.
Tizanidine has been approved by U.
Regional Analysis:
North America dominated the global tizanidine market in 2017. The presence of a large number of manufacturers coupled with high healthcare expenditure and awareness about available treatment options are some factors responsible for its largest share. In addition, increasing use of anti-anxiety medication among patients is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions owing to rising disposable income, improving economic conditions and an increase in consumer awareness about mental health issues. Moreover, government initiatives regarding drug pricing adjustment will also boost growth during the forecast period. For instance, in India generic version of Xanax was launched at a price lower than brand name version (Alprazolam).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for Tizanidine in the coming years.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as arthritis, spinal cord injuries, and cerebral palsy is rising rapidly across the globe, which is likely to boost the demand for Tizanidine in the near future.
- Growing awareness about benefits of Tizanidine: There has been a growing awareness about the benefits of Tizanidine among patients and healthcare professionals in recent years, which is likely to propel its market growth in the coming years.
- Technological advancements: The development of novel delivery technologies for Tizanidine such as transdermal patches and oral sprays will help expand its market potential in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tizanidine Market Research Report
By Type
2mg Tablet, 4mg Tablet, 2mg Capsules, 4mg Capsules, 6mg Capsules
By Application
Kids, Adults
By Companies
Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma, Dr. Reddy's Laboratories, Mylan, Oxford PharmaGenesis, Niche Generics Limited, CREDIT PHARMA, YABANG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Tizanidine Market Report Segments:
The global Tizanidine market is segmented on the basis of:
Types
2mg Tablet, 4mg Tablet, 2mg Capsules, 4mg Capsules, 6mg Capsules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Kids, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Actavis
- Teva
- Sandoz
- Acorda
- Unichem Laboratories
- APOTEX
- Sun Pharmaceutical
- CorePharma
- Dr. Reddy's Laboratories
- Mylan
- Oxford PharmaGenesis
- Niche Generics Limited
- CREDIT PHARMA
- YABANG
Highlights of The Tizanidine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2mg Tablet
- 4mg Tablet
- 2mg Capsules
- 4mg Capsules
- 6mg Capsules
- By Application:
- Kids
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tizanidine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tizanidine is a medication used to treat anxiety and panic disorders. It works by reducing the symptoms of these conditions, such as fear, anxiety, and panic attacks. Tizanidine is also used to prevent or reduce the severity of seizures in people with epilepsy.
Some of the major players in the tizanidine market are Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma, Dr. Reddy's Laboratories, Mylan, Oxford PharmaGenesis, Niche Generics Limited, CREDIT PHARMA, YABANG.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tizanidine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tizanidine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tizanidine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tizanidine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tizanidine Market Size & Forecast, 2018-2028
4.5.1 Tizanidine Market Size and Y-o-Y Growth
4.5.2 Tizanidine Market Absolute $ Opportunity
Chapter 5 Global Tizanidine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tizanidine Market Size Forecast by Type
5.2.1 2mg Tablet
5.2.2 4mg Tablet
5.2.3 2mg Capsules
5.2.4 4mg Capsules
5.2.5 6mg Capsules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tizanidine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tizanidine Market Size Forecast by Applications
6.2.1 Kids
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tizanidine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tizanidine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tizanidine Analysis and Forecast
9.1 Introduction
9.2 North America Tizanidine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tizanidine Market Size Forecast by Type
9.6.1 2mg Tablet
9.6.2 4mg Tablet
9.6.3 2mg Capsules
9.6.4 4mg Capsules
9.6.5 6mg Capsules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tizanidine Market Size Forecast by Applications
9.10.1 Kids
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tizanidine Analysis and Forecast
10.1 Introduction
10.2 Europe Tizanidine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tizanidine Market Size Forecast by Type
10.6.1 2mg Tablet
10.6.2 4mg Tablet
10.6.3 2mg Capsules
10.6.4 4mg Capsules
10.6.5 6mg Capsules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tizanidine Market Size Forecast by Applications
10.10.1 Kids
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tizanidine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tizanidine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tizanidine Market Size Forecast by Type
11.6.1 2mg Tablet
11.6.2 4mg Tablet
11.6.3 2mg Capsules
11.6.4 4mg Capsules
11.6.5 6mg Capsules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tizanidine Market Size Forecast by Applications
11.10.1 Kids
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tizanidine Analysis and Forecast
12.1 Introduction
12.2 Latin America Tizanidine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tizanidine Market Size Forecast by Type
12.6.1 2mg Tablet
12.6.2 4mg Tablet
12.6.3 2mg Capsules
12.6.4 4mg Capsules
12.6.5 6mg Capsules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tizanidine Market Size Forecast by Applications
12.10.1 Kids
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tizanidine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tizanidine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tizanidine Market Size Forecast by Type
13.6.1 2mg Tablet
13.6.2 4mg Tablet
13.6.3 2mg Capsules
13.6.4 4mg Capsules
13.6.5 6mg Capsules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tizanidine Market Size Forecast by Applications
13.10.1 Kids
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tizanidine Market: Competitive Dashboard
14.2 Global Tizanidine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Actavis
14.3.2 Teva
14.3.3 Sandoz
14.3.4 Acorda
14.3.5 Unichem Laboratories
14.3.6 APOTEX
14.3.7 Sun Pharmaceutical
14.3.8 CorePharma
14.3.9 Dr. Reddy's Laboratories
14.3.10 Mylan
14.3.11 Oxford PharmaGenesis
14.3.12 Niche Generics Limited
14.3.13 CREDIT PHARMA
14.3.14 YABANG
